GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sai Life Sciences Ltd

Sai Life Sciences allots 1,08,005 ESOP shares, raises capital

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 11:09 PM IST  ·  BSE ID: d3051240-17e3-496c-b917-41ca0fa544df
View Original BSE Filing (PDF)
💡
In Simple Terms
The company issued new shares to employees who exercised their stock options, increasing its total shares outstanding.
🤖 AI Summary
  • Sai Life Sciences allotted 1,08,005 equity shares under ESOP plans.
  • The allotment comprises 27,005 shares from ESOP 2008 and 81,000 from MESOP 2018.
  • This allotment increases the company's issued, subscribed, and paid-up equity share capital.
  • The company also approved its unaudited standalone and consolidated financial results for Q2 FY27.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Shares Allotted (ESOP 2008)
27,005 Equity Shares
Shares Allotted (MESOP 2018)
81,000 Equity Shares
Total Shares Allotted
1,08,005 Equity Shares
Face Value per Share
₹1/-
Previous Equity Share Capital
₹21,24,72,716/-
New Equity Share Capital
₹21,25,80,721/-
🏢 How This Affects the Company
💰
Financial Impact
The allotment of 1,08,005 equity shares, with a face value of ₹1/- each, resulted in an increase in the company's issued, subscribed, and paid-up equity share capital from ₹21,24,72,716/- to ₹21,25,80,721/-.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding the ESOP allotment.
👤
Who Is Affected
Shareholders are affected by the dilution of their ownership percentage due to the issuance of new equity shares. The total share capital increased from ₹21,24,72,716/- to ₹21,25,80,721/-.
🔍
Management Signal
The ESOP allotment and senior management appointments signal management's focus on employee incentives and strengthening the leadership team.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results to assess ongoing financial performance.
Confirmation of new senior management's integration and contributions.
Future ESOP exercises and their impact on share capital.
LOW RISK Routine ESOP allotment and management appointments pose no immediate material risk.
💡 Investor Takeaway
Sai Life Sciences allotted 1,08,005 equity shares via ESOPs, increasing capital to ₹21,25,80,721/-. The company also announced Q2 FY27 results and senior management appointments.
⚖️ Strengths & Concerns

✅ Positives

  • Allotment of equity shares upon exercise of ESOP options aligns employee interests with company growth.
  • Appointment of new Senior Management Personnel indicates ongoing organizational development and leadership expansion.
📅 Company Track Record
Prior filings indicate similar ESOP share allotments in September 2026 (80,600 shares) and October 2026 (54,500 shares), consistent with employee incentive programs.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many equity shares did Sai Life Sciences allot under its ESOP plans?
Sai Life Sciences allotted a total of 1,08,005 equity shares, consisting of 27,005 shares from ESOP 2008 and 81,000 shares from MESOP 2018.
What is the total face value of the newly allotted ESOP shares?
The total face value of the 1,08,005 newly allotted ESOP shares is ₹1,08,005/-, with each share having a face value of ₹1/-.
How did the ESOP allotment affect Sai Life Sciences' paid-up share capital?
The allotment increased the company's issued, subscribed, and paid-up equity share capital from ₹21,24,72,716/- to ₹21,25,80,721/-.
What other key decisions were made at the Board Meeting on November 5, 2026?
The Board approved the unaudited financial results for Q2 FY27 and appointed three individuals as Senior Management Personnel.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.